| Stuart Louis Siegal, MD | |
|
2010 Brookwood Medical Ctr Dr, Birmingham, AL 35209-6804 | |
| (205) 877-1990 | |
| (205) 824-8111 |
| Full Name | Stuart Louis Siegal |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 31 Years |
| Location | 2010 Brookwood Medical Ctr Dr, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508829623 | NPI | - | NPPES |
| 51516212 | Other | AL | BLUE CROSS/BLUE SHIELD |
| 51550442 | Other | AL | BLUE CROSS/BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 18307 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Vincent's Birmingham | Birmingham, AL | Hospital |
| Brookwood Baptist Medical Center | Birmingham, AL | Hospital |
| Riverview Regional Medical Center | Gadsden, AL | Hospital |
| Russell Medical Center | Alexander city, AL | Hospital |
| Usa Health University Hospital | Mobile, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiology Associates Of Birmingham, P.c. | 7214928571 | 37 |
| Radiology Associates Of Birmingham, P.c. | 7214928571 | 37 |
News Archive
New research by scientists at Schepens Eye Research Institute may help explain why the anti-cancer drug Avastin, which targets a growth factor responsible for creation of new blood vessels, causes potentially fatal brain inflammation in certain patients.
"In just over two decades, global health has gained a political visibility and status that some authors have called a political revolution," Ilona Kickbusch, director of the Global Health Programme at the Graduate Institute of International and Development Studies in Geneva, writes in a U.N. Chronicle opinion analysis.
Teva Pharmaceutical Industries Ltd., today announced that COPAXONE (glatiramer acetate injection), the #1 global therapy for relapsing multiple sclerosis, has been named the 2014 "Brand of The Year" by Pharmaceutical Executive Magazine, a leading print and online publication for the biopharmaceutical industry.
With viruses such as Ebola, MERS-CoV and Zika making global headlines, and the progressive development of antimicrobial resistance (AMR) worldwide, Edinburgh Research & Innovation (ERI), the commercialisation arm of the University of Edinburgh, has announced a new AIMday (Academic Industry Meeting day) for companies looking to find expertise and innovative solutions to dealing with the challenges of microbial infection.
› Verified 1 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
New research by scientists at Schepens Eye Research Institute may help explain why the anti-cancer drug Avastin, which targets a growth factor responsible for creation of new blood vessels, causes potentially fatal brain inflammation in certain patients.
"In just over two decades, global health has gained a political visibility and status that some authors have called a political revolution," Ilona Kickbusch, director of the Global Health Programme at the Graduate Institute of International and Development Studies in Geneva, writes in a U.N. Chronicle opinion analysis.
Teva Pharmaceutical Industries Ltd., today announced that COPAXONE (glatiramer acetate injection), the #1 global therapy for relapsing multiple sclerosis, has been named the 2014 "Brand of The Year" by Pharmaceutical Executive Magazine, a leading print and online publication for the biopharmaceutical industry.
With viruses such as Ebola, MERS-CoV and Zika making global headlines, and the progressive development of antimicrobial resistance (AMR) worldwide, Edinburgh Research & Innovation (ERI), the commercialisation arm of the University of Edinburgh, has announced a new AIMday (Academic Industry Meeting day) for companies looking to find expertise and innovative solutions to dealing with the challenges of microbial infection.
› Verified 1 days ago
| Entity Name | Norwood Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104879741 PECOS PAC ID: 8921996364 Enrollment ID: O20040308001107 |
News Archive
New research by scientists at Schepens Eye Research Institute may help explain why the anti-cancer drug Avastin, which targets a growth factor responsible for creation of new blood vessels, causes potentially fatal brain inflammation in certain patients.
"In just over two decades, global health has gained a political visibility and status that some authors have called a political revolution," Ilona Kickbusch, director of the Global Health Programme at the Graduate Institute of International and Development Studies in Geneva, writes in a U.N. Chronicle opinion analysis.
Teva Pharmaceutical Industries Ltd., today announced that COPAXONE (glatiramer acetate injection), the #1 global therapy for relapsing multiple sclerosis, has been named the 2014 "Brand of The Year" by Pharmaceutical Executive Magazine, a leading print and online publication for the biopharmaceutical industry.
With viruses such as Ebola, MERS-CoV and Zika making global headlines, and the progressive development of antimicrobial resistance (AMR) worldwide, Edinburgh Research & Innovation (ERI), the commercialisation arm of the University of Edinburgh, has announced a new AIMday (Academic Industry Meeting day) for companies looking to find expertise and innovative solutions to dealing with the challenges of microbial infection.
› Verified 1 days ago
| Entity Name | Radiology Associates Of Birmingham, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093778706 PECOS PAC ID: 7214928571 Enrollment ID: O20040524001193 |
News Archive
New research by scientists at Schepens Eye Research Institute may help explain why the anti-cancer drug Avastin, which targets a growth factor responsible for creation of new blood vessels, causes potentially fatal brain inflammation in certain patients.
"In just over two decades, global health has gained a political visibility and status that some authors have called a political revolution," Ilona Kickbusch, director of the Global Health Programme at the Graduate Institute of International and Development Studies in Geneva, writes in a U.N. Chronicle opinion analysis.
Teva Pharmaceutical Industries Ltd., today announced that COPAXONE (glatiramer acetate injection), the #1 global therapy for relapsing multiple sclerosis, has been named the 2014 "Brand of The Year" by Pharmaceutical Executive Magazine, a leading print and online publication for the biopharmaceutical industry.
With viruses such as Ebola, MERS-CoV and Zika making global headlines, and the progressive development of antimicrobial resistance (AMR) worldwide, Edinburgh Research & Innovation (ERI), the commercialisation arm of the University of Edinburgh, has announced a new AIMday (Academic Industry Meeting day) for companies looking to find expertise and innovative solutions to dealing with the challenges of microbial infection.
› Verified 1 days ago
| Entity Name | St Vincents Ambulatory Healthcare Network Llc |
|---|---|
| Entity Type | Part B Supplier - Independent Diagnostic Testing Facility (idtf) |
| Entity Identifiers | NPI Number: 1588190441 PECOS PAC ID: 1355608456 Enrollment ID: O20171128001387 |
News Archive
New research by scientists at Schepens Eye Research Institute may help explain why the anti-cancer drug Avastin, which targets a growth factor responsible for creation of new blood vessels, causes potentially fatal brain inflammation in certain patients.
"In just over two decades, global health has gained a political visibility and status that some authors have called a political revolution," Ilona Kickbusch, director of the Global Health Programme at the Graduate Institute of International and Development Studies in Geneva, writes in a U.N. Chronicle opinion analysis.
Teva Pharmaceutical Industries Ltd., today announced that COPAXONE (glatiramer acetate injection), the #1 global therapy for relapsing multiple sclerosis, has been named the 2014 "Brand of The Year" by Pharmaceutical Executive Magazine, a leading print and online publication for the biopharmaceutical industry.
With viruses such as Ebola, MERS-CoV and Zika making global headlines, and the progressive development of antimicrobial resistance (AMR) worldwide, Edinburgh Research & Innovation (ERI), the commercialisation arm of the University of Edinburgh, has announced a new AIMday (Academic Industry Meeting day) for companies looking to find expertise and innovative solutions to dealing with the challenges of microbial infection.
› Verified 1 days ago
| Entity Name | St Vincents Ambulatory Healthcare Network Llc |
|---|---|
| Entity Type | Part B Supplier - Independent Diagnostic Testing Facility (idtf) |
| Entity Identifiers | NPI Number: 1033646823 PECOS PAC ID: 1355608456 Enrollment ID: O20180626000597 |
News Archive
New research by scientists at Schepens Eye Research Institute may help explain why the anti-cancer drug Avastin, which targets a growth factor responsible for creation of new blood vessels, causes potentially fatal brain inflammation in certain patients.
"In just over two decades, global health has gained a political visibility and status that some authors have called a political revolution," Ilona Kickbusch, director of the Global Health Programme at the Graduate Institute of International and Development Studies in Geneva, writes in a U.N. Chronicle opinion analysis.
Teva Pharmaceutical Industries Ltd., today announced that COPAXONE (glatiramer acetate injection), the #1 global therapy for relapsing multiple sclerosis, has been named the 2014 "Brand of The Year" by Pharmaceutical Executive Magazine, a leading print and online publication for the biopharmaceutical industry.
With viruses such as Ebola, MERS-CoV and Zika making global headlines, and the progressive development of antimicrobial resistance (AMR) worldwide, Edinburgh Research & Innovation (ERI), the commercialisation arm of the University of Edinburgh, has announced a new AIMday (Academic Industry Meeting day) for companies looking to find expertise and innovative solutions to dealing with the challenges of microbial infection.
› Verified 1 days ago
| Entity Name | Cooper Green Mercy Health Services Authority An Affiliate Of Uab |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366073108 PECOS PAC ID: 0840629473 Enrollment ID: O20200402003238 |
News Archive
New research by scientists at Schepens Eye Research Institute may help explain why the anti-cancer drug Avastin, which targets a growth factor responsible for creation of new blood vessels, causes potentially fatal brain inflammation in certain patients.
"In just over two decades, global health has gained a political visibility and status that some authors have called a political revolution," Ilona Kickbusch, director of the Global Health Programme at the Graduate Institute of International and Development Studies in Geneva, writes in a U.N. Chronicle opinion analysis.
Teva Pharmaceutical Industries Ltd., today announced that COPAXONE (glatiramer acetate injection), the #1 global therapy for relapsing multiple sclerosis, has been named the 2014 "Brand of The Year" by Pharmaceutical Executive Magazine, a leading print and online publication for the biopharmaceutical industry.
With viruses such as Ebola, MERS-CoV and Zika making global headlines, and the progressive development of antimicrobial resistance (AMR) worldwide, Edinburgh Research & Innovation (ERI), the commercialisation arm of the University of Edinburgh, has announced a new AIMday (Academic Industry Meeting day) for companies looking to find expertise and innovative solutions to dealing with the challenges of microbial infection.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stuart Louis Siegal, MD 2090 Columbiana Rd, Suite 4400, Birmingham, AL 35216-2153 Ph: (205) 824-8000 | Stuart Louis Siegal, MD 2010 Brookwood Medical Ctr Dr, Birmingham, AL 35209-6804 Ph: (205) 877-1990 |
News Archive
New research by scientists at Schepens Eye Research Institute may help explain why the anti-cancer drug Avastin, which targets a growth factor responsible for creation of new blood vessels, causes potentially fatal brain inflammation in certain patients.
"In just over two decades, global health has gained a political visibility and status that some authors have called a political revolution," Ilona Kickbusch, director of the Global Health Programme at the Graduate Institute of International and Development Studies in Geneva, writes in a U.N. Chronicle opinion analysis.
Teva Pharmaceutical Industries Ltd., today announced that COPAXONE (glatiramer acetate injection), the #1 global therapy for relapsing multiple sclerosis, has been named the 2014 "Brand of The Year" by Pharmaceutical Executive Magazine, a leading print and online publication for the biopharmaceutical industry.
With viruses such as Ebola, MERS-CoV and Zika making global headlines, and the progressive development of antimicrobial resistance (AMR) worldwide, Edinburgh Research & Innovation (ERI), the commercialisation arm of the University of Edinburgh, has announced a new AIMday (Academic Industry Meeting day) for companies looking to find expertise and innovative solutions to dealing with the challenges of microbial infection.
› Verified 1 days ago
Dr. Garrett Colby, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Jt N342, Birmingham, AL 35249 Phone: 205-934-3108 Fax: 205-975-4413 | |
Drexell H Boggs, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1700 6th Ave S, Rm: 2253, Birmingham, AL 35233 Phone: 205-975-9399 Fax: 205-975-5184 | |
James Walker, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Joseph Smith, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Michelle M Mcnamara, MD Radiology Medicare: Medicare Enrolled Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-4011 | |
Sharda Mehar Bajaj, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1526 5th Ave S, Birmingham, AL 35233 Phone: 205-279-2860 | |
Gina Elizabeth Rebesco, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 625 19th St S, Birmingham, AL 35233 Phone: 205-975-0222 |